Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orion Oyj B | Helsinki | Healthcare | Pharmaceuticals | €5.79B | 26.7x | -0.73 | €41.21 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Orion Oyj A | Helsinki | Healthcare | Pharmaceuticals | €5.77B | 26.7x | -0.73 | €40.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Terveystalo | Helsinki | Healthcare | Healthcare Providers & Services | €1.27B | -55.4x | 0.12 | €10 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Revenio Group | Helsinki | Healthcare | Healthcare Equipment & Supplies | €759.05M | 41x | -3.21 | €28.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Pihlajalinna Oy | Helsinki | Healthcare | Healthcare Providers & Services | €215.80M | 29.2x | -1.11 | €9.60 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €188.50M | -3.9x | -0.65 | €1.88 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Oriola-KD Oyj A | Helsinki | Healthcare | Pharmaceuticals | €186.85M | -7.6x | 0.58 | €1.03 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Oriola-KD Oyj B | Helsinki | Healthcare | Pharmaceuticals | €175.79M | -8.1x | 0.56 | €0.97 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €150.55M | -5.9x | 1.08 | €1.76 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €123.70M | -3.5x | -3.74 | €2.10 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Optomed | Helsinki | Healthcare | Healthcare Equipment & Supplies | €111.03M | -25.5x | -0.97 | €5.98 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bioretec Oy | Helsinki | Healthcare | Healthcare Equipment & Supplies | €56.94M | €2.84 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Modulight Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €44.69M | -3.6x | 0.08 | €1.07 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €30.95M | 95.9x | 1.05 | €1.53 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Nexstim | Helsinki | Healthcare | Healthcare Equipment & Supplies | €19.62M | -14.5x | 0.07 | €2.91 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BBS-Bioactive Bone Substitutes Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €6.49M | -1.3x | -0.11 | €0.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
BBS | Helsinki | Healthcare | Healthcare Equipment & Supplies | €6.35M | -1.1x | -0.09 | €0.32 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |